Another technique, neurolytic celiac plexus block (NCPB) is claimed to be an effective method of pain control for pancreatic cancer pain, it can allow a reduction in opioid dose and an evident improvement of opioid-induced adverse effects or symptoms associated with the illness.
There are many traditional methods to relieve this pain (Warshaw et al., 1998), among which the effect of analgesic drug treatment is far from satisfaction, and the percutaneous neurolytic celiac plexus block may cause many complications like gastric fistula, retroperitoneal hematoma (Chen & Li, 1999).
The method and progress of the transdermal celiac plexus block. Int.
Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis.
Patients were excluded if they had received previous neurolytic celiac plexus block or other neurolytic blocks that could affect pain relief or had implanted epidural or intrathecal analgesic therapy.
Celiac plexus neurolysis (CPN) and celiac plexus block (CPB) have been considered the first-line adjuvant therapies for the treatment of pain in PanCa patients.[sup] Gunaratnam et al .
Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer.